Diagnosis of interstitial lung diseases

Jay H Ryu, Craig E. Daniels, Thomas E. Hartman, Eunhee S. Yi

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Interstitial lung diseases (ILDs), a broad heterogeneous group of parenchymal lung disorders, can be classified into those with known and unknown causes. The definitions and diagnostic criteria for several major forms of ILDs have been revised in recent years. Although well over 100 distinct entities of ILDs are recognized, a limited number of disorders, including idiopathic pulmonary fibrosis, sarcoidosis, and connective tissue disease-related ILDs, account for most ILDs encountered clinically. In evaluating patients with suspected ILD, the clinician should confirm the presence of the disease and then try to determine its underlying cause or recognized clinicopathologic syndrome. Clues from the medical history along with the clinical context and radiologic findings provide the initial basis for prioritizing diagnostic possibilities for a patient with ILD. High-resolution computed tomography of the chest has become an invaluable tool in the diagnostic process. A confident diagnosis can sometimes be made on the basis of high-resolution computed tomography and clinical context. Serologic testing can be helpful in selected cases. Histopathologic findings procured through bronchoscopic or surgical lung biopsy are often needed in deriving a specific diagnosis. An accurate prognosis and optimal treatment strategy for patients with ILDs depend on an accurate diagnosis, one guided by recent advances in our understanding of the causes and pathogenetic mechanisms of ILDs.

Original languageEnglish (US)
Pages (from-to)976-986
Number of pages11
JournalMayo Clinic Proceedings
Volume82
Issue number8
DOIs
StatePublished - 2007

Fingerprint

Interstitial Lung Diseases
Tomography
Pulmonary Sarcoidosis
Lung
Idiopathic Pulmonary Fibrosis
Connective Tissue Diseases
Thorax
Biopsy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ryu, J. H., Daniels, C. E., Hartman, T. E., & Yi, E. S. (2007). Diagnosis of interstitial lung diseases. Mayo Clinic Proceedings, 82(8), 976-986. https://doi.org/10.4065/82.8.976

Diagnosis of interstitial lung diseases. / Ryu, Jay H; Daniels, Craig E.; Hartman, Thomas E.; Yi, Eunhee S.

In: Mayo Clinic Proceedings, Vol. 82, No. 8, 2007, p. 976-986.

Research output: Contribution to journalArticle

Ryu, JH, Daniels, CE, Hartman, TE & Yi, ES 2007, 'Diagnosis of interstitial lung diseases', Mayo Clinic Proceedings, vol. 82, no. 8, pp. 976-986. https://doi.org/10.4065/82.8.976
Ryu, Jay H ; Daniels, Craig E. ; Hartman, Thomas E. ; Yi, Eunhee S. / Diagnosis of interstitial lung diseases. In: Mayo Clinic Proceedings. 2007 ; Vol. 82, No. 8. pp. 976-986.
@article{c00477067ccb4cea96757690ef811d9a,
title = "Diagnosis of interstitial lung diseases",
abstract = "Interstitial lung diseases (ILDs), a broad heterogeneous group of parenchymal lung disorders, can be classified into those with known and unknown causes. The definitions and diagnostic criteria for several major forms of ILDs have been revised in recent years. Although well over 100 distinct entities of ILDs are recognized, a limited number of disorders, including idiopathic pulmonary fibrosis, sarcoidosis, and connective tissue disease-related ILDs, account for most ILDs encountered clinically. In evaluating patients with suspected ILD, the clinician should confirm the presence of the disease and then try to determine its underlying cause or recognized clinicopathologic syndrome. Clues from the medical history along with the clinical context and radiologic findings provide the initial basis for prioritizing diagnostic possibilities for a patient with ILD. High-resolution computed tomography of the chest has become an invaluable tool in the diagnostic process. A confident diagnosis can sometimes be made on the basis of high-resolution computed tomography and clinical context. Serologic testing can be helpful in selected cases. Histopathologic findings procured through bronchoscopic or surgical lung biopsy are often needed in deriving a specific diagnosis. An accurate prognosis and optimal treatment strategy for patients with ILDs depend on an accurate diagnosis, one guided by recent advances in our understanding of the causes and pathogenetic mechanisms of ILDs.",
author = "Ryu, {Jay H} and Daniels, {Craig E.} and Hartman, {Thomas E.} and Yi, {Eunhee S.}",
year = "2007",
doi = "10.4065/82.8.976",
language = "English (US)",
volume = "82",
pages = "976--986",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "8",

}

TY - JOUR

T1 - Diagnosis of interstitial lung diseases

AU - Ryu, Jay H

AU - Daniels, Craig E.

AU - Hartman, Thomas E.

AU - Yi, Eunhee S.

PY - 2007

Y1 - 2007

N2 - Interstitial lung diseases (ILDs), a broad heterogeneous group of parenchymal lung disorders, can be classified into those with known and unknown causes. The definitions and diagnostic criteria for several major forms of ILDs have been revised in recent years. Although well over 100 distinct entities of ILDs are recognized, a limited number of disorders, including idiopathic pulmonary fibrosis, sarcoidosis, and connective tissue disease-related ILDs, account for most ILDs encountered clinically. In evaluating patients with suspected ILD, the clinician should confirm the presence of the disease and then try to determine its underlying cause or recognized clinicopathologic syndrome. Clues from the medical history along with the clinical context and radiologic findings provide the initial basis for prioritizing diagnostic possibilities for a patient with ILD. High-resolution computed tomography of the chest has become an invaluable tool in the diagnostic process. A confident diagnosis can sometimes be made on the basis of high-resolution computed tomography and clinical context. Serologic testing can be helpful in selected cases. Histopathologic findings procured through bronchoscopic or surgical lung biopsy are often needed in deriving a specific diagnosis. An accurate prognosis and optimal treatment strategy for patients with ILDs depend on an accurate diagnosis, one guided by recent advances in our understanding of the causes and pathogenetic mechanisms of ILDs.

AB - Interstitial lung diseases (ILDs), a broad heterogeneous group of parenchymal lung disorders, can be classified into those with known and unknown causes. The definitions and diagnostic criteria for several major forms of ILDs have been revised in recent years. Although well over 100 distinct entities of ILDs are recognized, a limited number of disorders, including idiopathic pulmonary fibrosis, sarcoidosis, and connective tissue disease-related ILDs, account for most ILDs encountered clinically. In evaluating patients with suspected ILD, the clinician should confirm the presence of the disease and then try to determine its underlying cause or recognized clinicopathologic syndrome. Clues from the medical history along with the clinical context and radiologic findings provide the initial basis for prioritizing diagnostic possibilities for a patient with ILD. High-resolution computed tomography of the chest has become an invaluable tool in the diagnostic process. A confident diagnosis can sometimes be made on the basis of high-resolution computed tomography and clinical context. Serologic testing can be helpful in selected cases. Histopathologic findings procured through bronchoscopic or surgical lung biopsy are often needed in deriving a specific diagnosis. An accurate prognosis and optimal treatment strategy for patients with ILDs depend on an accurate diagnosis, one guided by recent advances in our understanding of the causes and pathogenetic mechanisms of ILDs.

UR - http://www.scopus.com/inward/record.url?scp=34547640311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547640311&partnerID=8YFLogxK

U2 - 10.4065/82.8.976

DO - 10.4065/82.8.976

M3 - Article

C2 - 17673067

AN - SCOPUS:34547640311

VL - 82

SP - 976

EP - 986

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 8

ER -